Page last updated: 2024-08-25

nodakenin and Disease Models, Animal

nodakenin has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Chen, B; Kuang, G; Li, N; Lu, M; Mi, Y; Tan, K; Wang, L; Xu, X; Yan, K; Yi, N; Zhang, B1
Li, J; Tan, R; Wang, L; Zhao, S; Zhong, X1
Li, J; Liao, Y; Lin, X; Tan, R; Wang, L; Zhong, X1

Other Studies

3 other study(ies) available for nodakenin and Disease Models, Animal

ArticleYear
Nodakenin attenuates cartilage degradation and inflammatory responses in a mice model of knee osteoarthritis by regulating mitochondrial Drp1/ROS/NLRP3 axis.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt A

    Topics: Animals; Cartilage, Articular; Chondrocytes; Coumarins; Disease Models, Animal; Dynamins; Mice; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Osteoarthritis, Knee; Reactive Oxygen Species

2022
Nodakenin alleviated obstructive nephropathy through blunting Snail1 induced fibrosis.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:17

    Topics: Angelica; Animals; Anti-Inflammatory Agents; Coumarins; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Kidney; Kidney Failure, Chronic; Macrophages; Mice; NF-kappa B; Phosphorylation; Plant Roots; Signal Transduction; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta1; Ureteral Obstruction

2020
Nodakenin alleviates renal ischaemia-reperfusion injury via inhibiting reactive oxygen species-induced NLRP3 inflammasome activation.
    Nephrology (Carlton, Vic.), 2021, Volume: 26, Issue:1

    Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Disease Models, Animal; Drug Discovery; Glucosides; Inflammasomes; Interleukin-1beta; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha

2021